In non-syndromic hearing loss patients, p.L445W and p.M147T mutations in SLC26A4,followed by cell experiments, proved that the mutation prevented pendrin from targeting to the plasma membrane [21]. Here, SLC26A4 is linked to hearing loss disorder.